Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2017 | Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 186-187 | | | |
2017 | Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply. | Lin, D; Yang, HI; Hoang, J; Nguyen, MH | Alimentary pharmacology & therapeutics 45(1), 182-183 | | | |
2011 | Lifetime risk and gender difference of hepatocellular carcinoma among patients affected with chronic hepatitis B and C | Huang, YT; Jen, CL; Yang, HI; Lee, MH; Su, J; Lu, SN; Iloeje, UH; Chen, CJ; REVEAL-HBV/HCV Study Group | Journal of Clinical Oncology 29(27), 3643-3650 | | | |
2015 | Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk. | Huang, YT; Yang, HI; Liu, J; Lee, MH; Freeman, JR; Chen, CJ | EPIDEMIOLOGY 27(1), 14-20 | | | |
2016 | Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk. | Huang, YT; Yang, HI; Liu, J; Lee, MH; Freeman, JR; Chen, CJ | EPIDEMIOLOGY 27(1), 14-20 | | | |
2008 | Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C virus infection: a follow-up study in Taiwan | Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ | Gastroenterology 135,111-121 | | | |
2013 | Models predicting long-term risk of liver cirrhosis and hepatocellular carcinoma in chronic hepatitis B patients: risk scores integrating characteristics of host and hepatitis B virus | Lee, MH; Yang, HI; Liu, J; Batrla-Utermann, R; Jen, CL; Iloeje, UH; Jun, J; Lu, SN; You, SL; Wang, LY; Chen, CJ; REVEAL-HBV Study Group | Hepatology | | | |
2011 | Natural history of chronic hepatitis B REVEALed | Chen, CJ; Yang, HI | J Gastrolentrol Hepatol 26(4), 628-638 | | | |
2012 | Natural history of chronic hepatitis B: what exactly has REVEAL Revealed? | Iloeje, UH; Yang, HI; Chen, CJ | Liver Int 32, 1333-1341 | | | |
2016 | Natural history of HBV infection in the community | Chen, CJ; Yang, HI; Lee, MH; Liu, J; Hu, HH | Hepatitis B Virus in Human Diseases (Switzerland : Springer International Publishing Switzerland) | | | |
2010 | Nomograms for risk of heptocellular carcinoma in patients with chronic heaptitis B virus infection | Yang, HI; Sherman, M; Su, J; Chen, PJ; Liaw, YF; Iloeje, UH; Chen, CJ | J Clin Oncol 28:2437-2444 | | | |
2010 | Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. | Loomba, R; Yang, HI; Su, J; Brenner, D; Iloeje, U; Chen, CJ | Clin Gastroenterol Hepatol 8(10):891-898 | | | |
2017 | Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population | Wu, HC; Yang, HI; Wang, Q; Chen, CJ ; Santella, RM | Carcinogenesis 38(10), 1021-1028 | | | |
2015 | Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. | Lee, MH; Yang, HI; Lu, SN; Lin, YJ; Jen, CL; Wong, KH; Chan, SY; Chen, LC; Wang, LY; L’Italien, G; Yuan, Y; Chen, CJ | Scientific Reports 5, 17030 | | | |
2015 | Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System | Liu, J; Tseng, TC; Yang, HI; Lee, MH; Batrla-Utermann, R; Jen, CL; Lu, SN; Wang, LY; You, SL; Chen, PJ; Chen, CJ; Kao, JH | The Journal of infectious diseases 211(10), 1566-1573 | | | |
2015 | Preeclampsia and Retinopathy of Prematurity in Very Low-Birth-Weight Infants: A Population-based Study | Huang, HC; Yang, HI; Chou, HC; Chen, CY; Hsieh, WS; Tsou, KI; Tsao, PN | PLoS One 10(11), e0143248 (co-1st author) | | | |
2013 | Quantitative serum levels of hepatitis B surface antigen improve predictability of spontaneous eradication of hepatitis B virus in chronic hepatitis B patients | Liu, J; Lee, MH; Batrla-Utermann, R; Jen, CL; Iloeje, UH; Lu, SN; Wang, LY; You, SL; Hsiao, KC; Yang, HI; Chen, CJ; REVEAL-HBV Study Group | J Hepatol | | | |
2015 | R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability | Chen, HY; Yu, SL; Ho, BC; Su, KY; Hsu, YC; Chang, CS; Li, YC; Yang, SY; Hsu, PY; Ho, H; Chang, YH; Chen, CY; Yang, HI; Hsu, CP; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Hsia, JY; Chuang, CY; Yuan, S; Lee, MH; Liu, CH; Wu, GI; Hsiung, CA; Chen, YM; Wang, CL; Huang, MS; Yu, CJ; Chen, KY; Tsai, YH; Su, WC; Chen, HW; Chen, JJ; Chen, CJ; Chang, GC; Yang, PC; Li, KC | JOURNAL OF CLINICAL ONCOLOGY 33(20), 2303-2310 | | | |
2011 | Response to Letter by Lin et al Regarding Article, “Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease” | Lee, MH; Yang, HI; Wang, CH; Chen, CJ | Stroke 42(6), E390-391 | | | |
2017 | Response to RE: Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV) | Pan, WC; Yang, HI | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 109(1) | | | |